Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.70 |
| ▸ | PDE4A | P27815 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | CTSS | P25774 | 3/20 | 0.47 |
| ▸ | CTSK | P43235 | 3/20 | 0.47 |
| ▸ | CTSV | O60911 | 2/20 | 0.47 |
| ▸ | PLAT | P00750 | 2/20 | 0.47 |
| ▸ | CTSL | P07711 | 2/20 | 0.47 |
| ▸ | CTSH | P09668 | 2/20 | 0.47 |
| ▸ | CASP14 | P31944 | 2/20 | 0.47 |
| ▸ | CASP6 | P55212 | 2/20 | 0.47 |
| ▸ | CTSZ | Q9UBR2 | 2/20 | 0.47 |
| ▸ | BCL6 | P41182 | 1/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.46 |
| ▸ | CASP4 | P49662 | 1/20 | 0.46 |
| ▸ | CASP5 | P51878 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14294391 | 0.86 | RAB9A (0.62) | RAB9APDE4APTGS2CTSSCTSK | |
| SCHEMBL4838260 | 0.85 | RAB9A (0.62) | RAB9APDE4AAPPPTGS2CTSS | |
| SCHEMBL14268519 | 0.84 | RAB9A (0.49) | RAB9ACTSSCTSKCTSVPLAT | |
| SCHEMBL5033983 | 0.82 | APP (0.60) | RAB9AAPP | |
| SCHEMBL14293830 | 0.81 | RAB9A (0.67) | RAB9APDE4APTGS2CTSSCTSK | |
| SCHEMBL5031260 | 0.81 | RAB9A (0.62) | RAB9APDE4ACTSSCTSKCTSV | |
| SCHEMBL3503380 | 0.79 | RAB9A (0.80) | RAB9APDE4APTGS2CTSSCTSK | |
| SCHEMBL14293983 | 0.79 | RAB9A (0.53) | RAB9AAPPPTGS2CTSSCTSK | |
| SCHEMBL4832399 | 0.79 | RAB9A (0.53) | RAB9AAPPBCL6 | |
| SCHEMBL13326019 | 0.79 | RAB9A (0.66) | RAB9APDE4APTGS2CTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7335770-B2 | Triazine compounds and their analogs, compositions, and methods | REDDY U5 THERAPEUTICS, INC. (US) | 2008-02-26 | — | — | US | disclosed |
| US-7335770-B2 | Triazine compounds and their analogs, compositions, and methods | REDDY U5 THERAPEUTICS, INC. (US) | 2008-02-26 | — | — | US | disclosed |
| US-7335770-B2 | Triazine compounds and their analogs, compositions, and methods | REDDY U5 THERAPEUTICS, INC. (US) | 2008-02-26 | — | — | US | disclosed |
| US-20050227983-A1 | Triazine compounds and their analogs, compositions, and methods | DR. REDDY'S LABORATORIES LTD. (IN) | 2005-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050227983-A1 | Triazine compounds and their analogs, compositions, and methods | MYLK, SMAD3, GID4 | RAB9A 3708/4885PDE4A 1438/4885APP 2043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.